Editorial 'wrongly criticized' Sen. Coburn's 'due diligence' in reauthorizing PEPFAR, letter to editor says

NewsGuard 100/100 Score

A recent Washington Post editorial "wrongly criticized" Sen. Tom Coburn (R-Okla.) and "his colleagues for conducting due diligence" regarding legislation to reauthorize the President's Emergency Plan for AIDS Relief, Sen. Judd Gregg (N.H.), ranking Republican on the Senate Budget Committee's Appropriations Subcommittee on State and Foreign Operations, writes in a Post letter to the editor (Gregg, Washington Post, 6/5).

The Post editorial said that although PEPFAR "risks mutating into all-purpose development aid or taking on goals" that are "not only culturally sensitive but hard to measure in terms of progress" as it grows, the legislation "expands and modernizes America's signature global health initiative" and "could add to PEPFAR's proud record." The editorial added that Coburn and "six other Republicans" who have "exercised their prerogative to keep [the bill] off the Senate floor" should "get out of the way" (Kaiser Daily HIV/AIDS Report, 6/2).

According to Gregg, any "dramatic increase in HIV/AIDS spending would be offset by a funding decrease for other international programs that are important to America's security interests." He adds that the editorial "regrettably stopped short of suggesting that the State Department negotiate sustainability strategies and cost-sharing agreements" with PEPFAR focus countries to "better define America's role in the global fight against" HIV/AIDS. Gregg writes that if the Post "knows the costs of PEPFAR over the life of the program or its impact on other foreign aid accounts, it should share that information," concluding, "Until then, the Senate is doing its job in considering all consequences of a $50 billion reauthorization of PEPFAR" (Washington Post, 6/5).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers receive NIH grant to help develop gene therapy for HIV